354 related articles for article (PubMed ID: 28421332)
41. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
Sahebkar A; Saboni N; Pirro M; Banach M
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):19-24. PubMed ID: 27897416
[TBL] [Abstract][Full Text] [Related]
42. Are Chronic Pain Syndromes the Reason for Statin-associated Muscle Symptoms?
Sheinin R; Nogueira AR; Bragazzi NL; Watad A; Tiosano S; Gonen T; Sharif K; Kameri Y; Amital H; Amital D; Cohen H
Isr Med Assoc J; 2022 Nov; 24(11):719-726. PubMed ID: 36436038
[TBL] [Abstract][Full Text] [Related]
43. [Statin-associated muscle symptoms : Current management in 2018].
Kosinski C; Tran C; Kuntzer T; Rodondi N; Collet TH
Rev Med Suisse; 2018 Feb; 14(596):462-469. PubMed ID: 29489126
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of statin-associated skeletal muscle-associated symptoms.
Bouitbir J; Sanvee GM; Panajatovic MV; Singh F; Krähenbühl S
Pharmacol Res; 2020 Apr; 154():104201. PubMed ID: 30877064
[TBL] [Abstract][Full Text] [Related]
45. Increased creatine kinase with statin treatment may identify statin-associated muscle symptoms.
Taylor BA; Panza G; Thompson PD
Int J Cardiol; 2016 Apr; 209():12-3. PubMed ID: 26874453
[No Abstract] [Full Text] [Related]
46. Neuromuscular Effects of Rocuronium Bromide in Patients in Statin Therapy for at least Three Months.
Ren H; Lv H
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):582-587. PubMed ID: 27234897
[TBL] [Abstract][Full Text] [Related]
47. An assessment by the Statin Muscle Safety Task Force: 2014 update.
Rosenson RS; Baker SK; Jacobson TA; Kopecky SL; Parker BA; The National Lipid Association's Muscle Safety Expert Panel
J Clin Lipidol; 2014; 8(3 Suppl):S58-71. PubMed ID: 24793443
[TBL] [Abstract][Full Text] [Related]
48. Statin intolerance.
Laufs U; Scharnagl H; März W
Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
[TBL] [Abstract][Full Text] [Related]
49. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
[TBL] [Abstract][Full Text] [Related]
50. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
51. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis.
Irwin JC; Khalesi S; Fenning AS; Vella RK
Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224
[TBL] [Abstract][Full Text] [Related]
52. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries.
Rosenson RS; Gandra SR; McKendrick J; Dent R; Wieffer H; Cheng LI; Catapano AL; Oh P; Kees Hovingh G; Stroes ES
Cardiovasc Drugs Ther; 2017 Apr; 31(2):187-195. PubMed ID: 28466399
[TBL] [Abstract][Full Text] [Related]
53. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
[TBL] [Abstract][Full Text] [Related]
54. Statins and muscle pain.
Pergolizzi JV; Coluzzi F; Colucci RD; Olsson H; LeQuang JA; Al-Saadi J; Magnusson P
Expert Rev Clin Pharmacol; 2020 Mar; 13(3):299-310. PubMed ID: 32089020
[No Abstract] [Full Text] [Related]
55. Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but….
Zaleski AL; Taylor BA; Thompson PD
Adv Nutr; 2018 Jul; 9(4):519S-523S. PubMed ID: 30032220
[TBL] [Abstract][Full Text] [Related]
56. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
[TBL] [Abstract][Full Text] [Related]
57. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
[TBL] [Abstract][Full Text] [Related]
58. Modeling statin myopathy in a human skeletal muscle microphysiological system.
Ananthakumar A; Liu Y; Fernandez CE; Truskey GA; Voora D
PLoS One; 2020; 15(11):e0242422. PubMed ID: 33237943
[TBL] [Abstract][Full Text] [Related]
59. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
60. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.
Sarzani R; Allevi M; Giulietti F; Sarnari S; Scorcella S; Di Agostini A; Turri P; Di Pentima C; Spannella F
Nutr Metab Cardiovasc Dis; 2024 Jan; 34(1):136-144. PubMed ID: 37798232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
